Apellis Pharmaceuticals Inc (APLS)
34.14
+1.50
(+4.61%)
USD |
NASDAQ |
Nov 27, 16:00
34.14
0.00 (0.00%)
After-Hours: 19:37
Apellis Pharmaceuticals Shares Outstanding: 124.39M for Oct. 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 29, 2024 | 124.39M |
September 30, 2024 | 122.07M |
July 25, 2024 | 121.77M |
June 30, 2024 | 121.69M |
May 01, 2024 | 121.37M |
April 08, 2024 | 121.29M |
March 31, 2024 | 121.26M |
February 20, 2024 | 120.58M |
December 31, 2023 | 119.56M |
October 24, 2023 | 118.50M |
September 30, 2023 | 118.36M |
July 24, 2023 | 117.74M |
June 30, 2023 | 117.58M |
May 01, 2023 | 116.46M |
April 03, 2023 | 116.18M |
March 31, 2023 | 116.18M |
February 27, 2023 | 115.30M |
February 15, 2023 | 111.29M |
December 31, 2022 | 110.77M |
November 01, 2022 | 110.58M |
September 30, 2022 | 110.48M |
August 04, 2022 | 109.87M |
August 01, 2022 | 108.86M |
June 30, 2022 | 106.84M |
April 29, 2022 | 106.52M |
Date | Value |
---|---|
April 05, 2022 | 106.47M |
March 31, 2022 | 106.44M |
March 28, 2022 | 106.30M |
February 23, 2022 | 97.73M |
December 31, 2021 | 97.52M |
November 18, 2021 | 97.36M |
November 02, 2021 | 87.30M |
September 30, 2021 | 87.22M |
August 03, 2021 | 87.00M |
July 23, 2021 | 86.49M |
June 30, 2021 | 80.96M |
April 23, 2021 | 80.50M |
April 05, 2021 | 80.44M |
March 31, 2021 | 80.44M |
February 22, 2021 | 80.38M |
January 26, 2021 | 79.64M |
December 31, 2020 | 76.13M |
October 28, 2020 | 75.74M |
September 30, 2020 | 75.70M |
July 27, 2020 | 75.60M |
June 30, 2020 | 75.60M |
April 24, 2020 | 75.51M |
April 13, 2020 | 75.50M |
March 31, 2020 | 75.40M |
February 21, 2020 | 75.32M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
63.94M
Minimum
Dec 31 2019
124.39M
Maximum
Oct 29 2024
99.36M
Average
106.46M
Median
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Ionis Pharmaceuticals Inc | 157.90M |
EyePoint Pharmaceuticals Inc | 68.25M |
Cassava Sciences Inc | 48.11M |
Macrogenics Inc | 62.76M |